BX Swiss TOP 30 CHF
1.278,99
PKT
+2,48
PKT
+0,19
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
13.11.14 | Novartis buy | UBS AG | |
12.11.14 | Zurich Insurance Hold | Deutsche Bank AG | |
11.11.14 | Zurich Insurance Verkaufen | Independent Research GmbH | |
11.11.14 | Zurich Insurance Conviction Buy | Goldman Sachs Group Inc. | |
11.11.14 | Swiss Re buy | Deutsche Bank AG | |
10.11.14 | Zurich Insurance Halten | DZ-Bank AG | |
10.11.14 | Novartis buy | Jefferies & Company Inc. | |
10.11.14 | Roche buy | Jefferies & Company Inc. | |
10.11.14 | Swiss Re buy | Kepler Cheuvreux | |
07.11.14 | Swiss Re Verkaufen | DZ-Bank AG | |
07.11.14 | Holcim overweight | JP Morgan Chase & Co. | |
07.11.14 | Roche buy | UBS AG | |
07.11.14 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
07.11.14 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
07.11.14 | Zurich Insurance Hold | S&P Capital IQ | |
06.11.14 | Holcim buy | Deutsche Bank AG | |
06.11.14 | Holcim Sell | S&P Capital IQ | |
06.11.14 | Holcim buy | Deutsche Bank AG | |
06.11.14 | Holcim buy | Kepler Cheuvreux | |
05.11.14 | UBS Verkaufen | Bankhaus Lampe KG | |
05.11.14 | Holcim Neutral | BNP PARIBAS | |
05.11.14 | Holcim Neutral | BNP PARIBAS | |
05.11.14 | UBS Neutral | Credit Suisse Group | |
05.11.14 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
04.11.14 | Holcim buy | UBS AG | |
04.11.14 | Holcim Neutral | Credit Suisse Group | |
04.11.14 | Holcim overweight | JP Morgan Chase & Co. | |
03.11.14 | Nestlé overweight | JP Morgan Chase & Co. | |
03.11.14 | Holcim buy | S&P Capital IQ | |
03.11.14 | Zurich Insurance Outperform | Credit Suisse Group | |
03.11.14 | UBS Sell | Société Générale Group S.A. (SG) | |
03.11.14 | Zurich Insurance Outperform | Credit Suisse Group | |
31.10.14 | Holcim buy | UBS AG | |
31.10.14 | Novartis Halten | Independent Research GmbH | |
30.10.14 | Nestlé Neutral | Citigroup Corp. | |
29.10.14 | UBS buy | Deutsche Bank AG | |
29.10.14 | Novartis Hold | Deutsche Bank AG | |
29.10.14 | UBS overweight | JP Morgan Chase & Co. | |
29.10.14 | UBS overweight | Morgan Stanley | |
29.10.14 | Swiss Re Neutral | UBS AG |